Senphonix Inc


Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.

Industries

N/A

Nr. of Employees

small (1-50)

Senphonix Inc

59 Fourth Street West, Suite 21D, St. Paul, MN 55102


Products

Adhesive-free mesh vitals sleeve (prototype/MVP)

An adhesive-free, breathable mesh sleeve that wirelessly charges and continuously captures clinical-grade biosignals (heart rate, respiration, temperature, movement) and transmits encrypted data to a HIPAA-compliant cloud for EHR integration and alerting.


Services

Cloud service to ingest encrypted biosignals from wearable devices, store data securely, and integrate with electronic health record systems and alerting workflows; designed for subscription/pay-as-you-go delivery.

Services to deploy continuous biosignals monitoring for clinical studies, including device provisioning, data capture, and integration with trial data systems to improve data robustness and enable remote participation.

Expertise Areas

  • Continuous patient monitoring
  • Wearable biosensor design
  • Cloud-based clinical data platforms
  • EHR integration and interoperability
  • Show More (6)

Key Technologies

  • Wearable biosensors
  • Mesh/skin-like medical textiles
  • Wireless power transfer (wireless charging)
  • Bluetooth Low Energy (BLE)
  • Show More (6)

News & Updates

Academic paper by Dr. Gutruf and colleagues on biosymbiotic platforms for chronic monitoring.

Academic paper discussing the challenges and opportunities in wearable biosignal monitoring.

Academic paper on electromagnetic design for wearable biosymbiotic devices.

Senphonix holds an exclusive, worldwide license from the University of Arizona to the core intellectual property utilized in its SleeveSense product.

Market research conducted by MarketWise Advising in April 2025 validated a 98% market need/solution match for SleeveSense, with 95% confidence (n=402; +/- 5% error rate).

Senphonix's leadership team has deep experience in bringing breakthrough healthcare technologies to market and scaling them successfully.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.